Research output per year
Research output per year
Search results
-
2021
Developing a series of inhaled reversible peptide inhibitors against Cathepsin S
Suleiman, H., Taggart, C., Scott, C. & Williams, R., 25 Feb 2021, Winter School (Medicine, Dentistry and Biomedical Sciences) Meeting 2021: Proteinases and their Inhibitors.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
-
2017
Design and validation of selective and potent cathepsin S inhibitors as anti-cancer therapy
Scott, C., Cogo, F. & Williams, R., 11 Mar 2017, QUB Winter School (Medicine, Dentistry and Biomedical Sciences) Meeting 2017: Proteinases and their Inhibitors.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
-
2016
ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.
Weir, J.-A., Gilliland, P., Fuchs, M.-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research InstituteResearch output: Chapter in Book/Report/Conference proceeding › Conference contribution